Sterling Capital Management LLC Acquires 996 Shares of Teleflex Incorporated (NYSE:TFX)

Sterling Capital Management LLC grew its stake in Teleflex Incorporated (NYSE:TFX) by 55.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,791 shares of the medical technology company’s stock after buying an additional 996 shares during the period. Sterling Capital Management LLC’s holdings in Teleflex were worth $497,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the stock. Headlands Technologies LLC bought a new stake in Teleflex during the fourth quarter valued at about $29,000. Avior Wealth Management LLC boosted its position in shares of Teleflex by 81.2% during the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock valued at $50,000 after acquiring an additional 125 shares in the last quarter. IFP Advisors Inc raised its stake in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after acquiring an additional 217 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after acquiring an additional 94 shares during the last quarter. Finally, R Squared Ltd bought a new position in Teleflex during the fourth quarter worth about $64,000. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

TFX has been the topic of a number of recent analyst reports. Truist Financial reduced their price target on shares of Teleflex from $149.00 to $140.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Piper Sandler restated a “neutral” rating and issued a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $169.63.

Teleflex Price Performance

NYSE TFX opened at $129.57 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The firm’s 50 day moving average is $144.52 and its 200-day moving average is $178.76. The company has a market capitalization of $6.01 billion, a PE ratio of 25.76, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.05%. Teleflex’s dividend payout ratio (DPR) is currently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.